LRRK2 and Parkinson disease: Human dopaminergic neurons of sporadic and LRRK2 PD patients (carrying the G2019S mutation) showed markedly less neurites per dopaminergic neuron and shorter neurites in both patient cohorts after 75 days of neuronal differentiation.